" At TÜSIAD, we will continue to monitor the government policies to ensure they continue promoting and developing Turkey’s good business environment for international companies."
In Conversation
"As a mid-cap, family owned and run entity that is endowed with a very strong sense of company culture and mission, we found we were able…
MSD globally is committed to being a primary research-intense biopharmaceutical company, and R&D is at the heart of our organization. The intent of the planned Discovery…
"Turkey does have the potential to grow between three and four percent already irrespective of stimulus, so with the additional help these figures can double easily"
"For a life sciences company, there is the access to our outstanding universities and the quality of research within. Their sheer number has been key to…
"Our mission is to improve patient healthcare by bringing high quality and validated genomic knowledge into everyday clinical practice."
"Our goal at Takeda is to be the most respected company in each of the therapeutic areas in which we are active, to be competitive, but…
"Historically, clinical research has maintained a particularly high quality in Portugal. Moreover, in the last ten years, despite the economic restraints and the squeeze we have…
The AGP feels that the patient should have access to information, so the alliance strives to accommodate this
"After spending 25 years looking at how pharmaceuticals are made, my major assertion was that active drug substance has been manufactured according to a process flowsheet…
"We’ve actually entered an unprecedented phase for the company, having launched more products in the past four years than in the entire decade before"
"In Portugal, we have effectively changed the way that companies evaluate and assess the market, both regarding performance, competitiveness and in evaluation of commercial areas effectiveness."
